Clinical case of hereditary hemochromatosis

Cover Page

Abstract


The article presents a clinical case demonstrating the difficulties of timely diagnosis of hereditary hemochromatosis, presents data on modern diagnosis and approaches to the treatment of the disease according to existing clinical guidelines. The described clinical case of hereditary hemochromatosis is associated with a homozygous mutation of C282Y in HFE gene in a 58-year-old patient and his twin brother. Initially, signs of iron deposition in the liver were found on MRI of the abdominal cavity. In laboratory analyses, the patient was found to have an increased level of serum iron - 40 µmol/l and ferritin - 1340 ng/ml. Subsequently, the investigation of HFE gene mutations was carried out and a mutation of C282Y in homozygous form (genotype A/A) was found, which is a molecular genetic confirmation of hereditary hemochromatosis of type 1. At the same time, the patient's twin brother at the targeted examination had the serum iron level of 36 µmol/l, the ferritin level of 600 ng/ml, and also the mutation of HFE gene, the allelic variant of A/A. The results of liver fibroelastometry of the patient correlate with the degree of fibrosis F1 by Metavir scale. Timely started therapeutic phlebotomies led to improved clinical and laboratory parameters of iron metabolism while maintaining normal levels of red blood cells and hemoglobin.


A V Solov’eva

Ryazan State Medical University

Author for correspondence.
Email: savva2005@bk.ru
Ryazan, Russia

O V Kodyakova

Ryazan regional clinical hospital

Email: savva2005@bk.ru
Ryazan, Russia

I N Nikitina

Ryazan State Medical University

Email: savva2005@bk.ru
Ryazan, Russia

N P Fomenko

Ryazan State Medical University

Email: savva2005@bk.ru
Ryazan, Russia

D R Rakita

Group of companies “Razvitie”

Email: savva2005@bk.ru
Ryazan, Russia

  • Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet. 1996; 13: 399–408. doi: 10.1038/ng0896-399.
  • Adams P.C., Reboussin D.M., Barton J.C., et al. Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med. 2005; 352: 1769–1778. doi: 10.1056/NEJMoa041534.
  • Powell L.W., Dixon J.L., Ramm G.A., et al. Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch. Intern. Med. 2006; 166: 294–301. doi: 10.1001/archinte.166.3.294.
  • Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., Robson K.J. Global prevalence of putative haemochromatosis mutations. J. Med.Genet. 1997; 34 (4): 275–278. doi: 10.1136/jmg.34.4.275.
  • Distante S., Robson K.J., Graham-Campbell J., et al. The origin and spread of the HFE-C282Y haemochromatosis mutation. Hum Genet. 2004; 115 (4): 269–279. doi: 10.1007/s00439-004-1152-4.
  • Kelleher T., Ryan E., Barrett S., et al. DMT1 gene­tic variability is not responsible for phenotype variability in hereditary hemochromatosis. Blood Cells Mol. Dis. 2004; 33 (1): 35–39. doi: 10.1016/j.bcmd.2004.04.005.
  • Bauduer F., Scribans C., Degioanni A., et al. Distribution of the C282Y and H63D polymorphisms in here­ditary hemochromatosis patients from the French Basque Country. Ann. Hematol. 2005; 84 (2): 99–102. doi: 10.1007/s00277-004-0957-5.
  • Zborovskiy S.S., Misyurin A.B., Shcherbinina S.P. Pervyy opyt geneticheskogo testirovaniya nasledstvennogo gemokhromatoza v Rossii. Gematologiya i transfuziologiya. 2001; 46 (3): 64–65. (In Russ.)
  • Mikhaylova S.V., Kobzev V.F., Romashchenko A.G., et al. Prevalence of C282Y, H63D and S65C allels of HFE gene and predisposition to iron metabolism disorders in the Russian population. Rossiyskiy zhurnal gastroenterologii, gepatologii, koloproktologii. 2001; 11 (4): 13–17. (In Russ.)
  • Hollerer I., Bachmann A., Muckenthaler M.U. Pathophysiological consequences and benefits of HFE mutations: 20 years of research. Haematologica. 2017; 102: 809–817. doi: 10.3324/haematol.2016.160432.
  • Tavill A.S. American for the Study of Liver D, American College of G., American Gastroenterological F. Diagnosis and managment of hemochromatosis. Hepa­tology. 2001; 33: 1321–1328. doi: 10.1053/jhep.2001.24783.
  • Kamruzzaman S. Medical and demographic situation and smernost diseases of the digestive system in the Tver region. Rossiyskiy mediko-biologicheskiy vestnik im. akademika I.P. Pavlova. 2011; 19 (1): 63–67. (In Russ.)
  • Ruefer A., Bapst C., Benz R., Bremerich J., et al. Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload. Swiss. Med. Wkly. 2017; 8 (147): 14550. doi: 10.4414/smw.2017.14550.
  • Adams P., Altes A., Brissot P., et al. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype. Hepatol. Int. 2018; 12 (2): 83–86. doi: 10.1007/s12072-018-9855-0.
  • European Association For The Study Of The Li­ver / EASL clinical practice guidelines for HFE hemochromatosis. J. Hepatol. 2010; 53 (1): 3–22. doi: 10.1016/j.jhep.2010.03.001.

Views

Abstract - 9

PDF (Russian) - 21

PlumX


© 2018 Solov’eva A.V., Kodyakova O.V., Nikitina I.N., Fomenko N.P., Rakita D.R.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.


Свидетельство о регистрации СМИ ЭЛ № ФС 77-70434 от 20 июля 2017 года выдано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор)